Industry Pipeline - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Industry Pipeline
Interphex Showcase 2010.

Pharmaceutical Technology
Volume 34, Issue 4, pp. 128-135



Quality-management system
Spectrum's Quality-Management System has achieved the International Organization for Standardization's (ISO) 9001:2008 standard. Since 1994, compliance with ISO standards and with the US Food and Drug Administration's current good manufacturing practice regulations have formed the foundation of Spectrum's Integrated Quality system, which is designed to help products get to market quickly. Spectrum Chemical, New Brunswick, NJ http://www.spectrumchemical.com/ tel. 800.901.5516



Powder-into-capsule services
Xcelience offers powder-into-capsule services that enable clients to fill small amounts of active pharmaceutical ingredients (APIs) directly into capsules and speed the time to first-in-human studies. The company's three dedicated systems provide flexibility, expertise, and high capacity. Xcelience has processed more than 30 APIs and 100 batches. Xcelience, Tampa, FL http://www.xcelience.com/ tel. 206.525.5852



Contract analytical services
Impact Analytical provides experienced scientists and state-of-the-art laboratories to provide pharmaceutical drug-development support and analytical services, including release testing, research support, methods validation and development, stability studies, actives quantitation, and raw-material testing. The company is certified by the International Organization for Standardization. Impact Analytical, Midland, MI http://www.impactanalytical.com/ tel. 989.832.5555



Contract manufacturing
Therapex is a contract manufacturer for oral liquid and topical healthcare products. The company offers turnkey services such as product development, technology transfer, and commercial manufacturing and packaging. In-house services include validation, quality control testing, method development, and stability testing. Therapex has more than 300 employees at its FDA-certified plant. Therapex, Anjou, Canada http://www.therapex.com/ tel. 800.465.5820



Development services
Vetter Development Service (VDS) supports drug-development projects from inception to market launch and beyond. The company offers clinical manufacturing from preclinical development through Phase II, with scale-up and transfer to its commercial manufacturing facilities. VDS fills clinical-trial materials under strict aseptic standards and according to good manufacturing practice. Vetter Pharma International, Ravensburg, Germany http://www.vetter-pharma.com/ tel. +49 751 3700 0


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
How does your company apply quality-by-design (QbD) principles to manufacturing processes?
To all processes for both new and legacy products
To all process for new products only
To select process for new products only
To select processes for both new and legacy products
Do not use QbD
To all processes for both new and legacy products
21%
To all process for new products only
13%
To select process for new products only
26%
To select processes for both new and legacy products
21%
Do not use QbD
21%
View Results
UPCOMING CONFERENCES

Programs for Investigational and Pre-Launch Drugs
Philadelphia, PA
July 17-18, 2013
Request Brochure

Strategic Pipeline Planning & Portfolio Valuation
Philadelphia, PA
August 13-14, 2013
Request Brochure

MES 2013 - Forum on Manufacturing Execution Systems
Philadelphia, PA
August 14-15, 2013
Request Brochure

Mobile Innovation for the Life Sciences Industry
Philadelphia, PA
August 20-21, 2013
Request Brochure

See All Conferences >>

Eric Langer Outsourcing Outlook Eric LangerOutsourcing's Modest Role as a Cost-Containment Strategy
Patricia Van Arnum Ingredients Insider Patricia Van ArnumIntellectual Property Battles in Solid-State Chemistry
Nathan Jessop Industry Insider Nathan Jessop Campaign Against Counterfeit Drugs Continues
Lynn Torbeck Statistical Solutions Lynn D. TorbeckCompositing Samples and the Risk to Product Quality
 More
Global Biosimilars Market to Reach $2.445 Billion in 2013
Adapting to Change
AstraZeneca and Exco InTouch Collaborate to Augment Current COPD Pathways
Overcoming the Challenges in Biopharmaceutical Stability Testing
PhRMA Dismayed by Special 301 Report
FindPharma Custom Search
Source: Pharmaceutical Technology,
Click here